ATXN3 and neuroblastoma: For Annexin V/PI flow cytometry, under the condition of cisplatin treatment, the apoptotic rate of NB cells with ATXN3 siRNAs transfected was significantly lower than control siRNA group (For cisplatin treatment, in AS cells, ATXN3 siRNA #1 and #2 vs. control siRNA: 27.4% and 23.3% vs. 46.1%, P<0.001, Figure 5E, right; in BE2 cells, ATXN3 siRNA vs. control siRNA: 22.8% vs. 34.2%, P<0.01, Figure 5F, right).